Which has higher valuation and earnings, EXPO or VSEC?

Exponent has higher earnings, but lower revenue than VSE. Exponent is trading at a lower price-to-earnings ratio than VSE, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Exponent $582.01M 5.22 $106.01M $2.15 29.15 VSE $1.11B 4.91 $11.70M $2.37 82.11

Is EXPO or VSEC more profitable?

Exponent has a net margin of 18.07% compared to VSE's net margin of 4.95%. Exponent's return on equity of 27.94% beat VSE's return on equity. Company Net Margins Return on Equity Return on Assets Exponent 18.07% 27.94% 14.59% VSE 4.95% 6.56% 4.68%

Does the media refer more to EXPO or VSEC?

In the previous week, Exponent had 3 more articles in the media than VSE. MarketBeat recorded 7 mentions for Exponent and 4 mentions for VSE. VSE's average media sentiment score of 1.22 beat Exponent's score of 0.37 indicating that VSE is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Exponent 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral VSE 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, EXPO or FCN?

FTI Consulting has higher revenue and earnings than Exponent. FTI Consulting is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Exponent $582.01M 5.22 $106.01M $2.15 29.15 FTI Consulting $3.79B 1.28 $270.87M $8.41 19.12

Is EXPO or FCN more profitable?

Exponent has a net margin of 18.07% compared to FTI Consulting's net margin of 6.88%. Exponent's return on equity of 27.94% beat FTI Consulting's return on equity. Company Net Margins Return on Equity Return on Assets Exponent 18.07% 27.94% 14.59% FTI Consulting 6.88% 15.14% 7.63%

Does the media favor EXPO or FCN?

In the previous week, Exponent had 1 more articles in the media than FTI Consulting. MarketBeat recorded 7 mentions for Exponent and 6 mentions for FTI Consulting. Exponent's average media sentiment score of 0.37 beat FTI Consulting's score of 0.30 indicating that Exponent is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Exponent 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral FTI Consulting 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has higher earnings & valuation, EXPO or IHS?

IHS has higher revenue and earnings than Exponent. IHS is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Exponent $582.01M 5.22 $106.01M $2.15 29.15 IHS $1.58B 1.73 $143.60M $0.53 15.41

Is EXPO or IHS more profitable?

Exponent has a net margin of 18.07% compared to IHS's net margin of 10.74%. Exponent's return on equity of 27.94% beat IHS's return on equity. Company Net Margins Return on Equity Return on Assets Exponent 18.07% 27.94% 14.59% IHS 10.74% -1,351.44% 12.81%

Does the media favor EXPO or IHS?

In the previous week, Exponent had 3 more articles in the media than IHS. MarketBeat recorded 7 mentions for Exponent and 4 mentions for IHS. Exponent's average media sentiment score of 0.37 beat IHS's score of 0.14 indicating that Exponent is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Exponent 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral IHS 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation & earnings, EXPO or CBZ?

CBIZ has higher revenue and earnings than Exponent. CBIZ is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Exponent $582.01M 5.22 $106.01M $2.15 29.15 CBIZ $2.76B 0.81 $115.44M $2.49 16.80

Is EXPO or CBZ more profitable?

Exponent has a net margin of 18.07% compared to CBIZ's net margin of 5.57%. Exponent's return on equity of 27.94% beat CBIZ's return on equity. Company Net Margins Return on Equity Return on Assets Exponent 18.07% 27.94% 14.59% CBIZ 5.57% 12.62% 5.17%

Does the media favor EXPO or CBZ?

In the previous week, Exponent had 5 more articles in the media than CBIZ. MarketBeat recorded 7 mentions for Exponent and 2 mentions for CBIZ. CBIZ's average media sentiment score of 0.93 beat Exponent's score of 0.37 indicating that CBIZ is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Exponent 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral CBIZ 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor EXPO or HURN?

In the previous week, Exponent had 4 more articles in the media than Huron Consulting Group. MarketBeat recorded 7 mentions for Exponent and 3 mentions for Huron Consulting Group. Huron Consulting Group's average media sentiment score of 0.68 beat Exponent's score of 0.37 indicating that Huron Consulting Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Exponent 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Huron Consulting Group 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Exponent (EXPO) Competitors

$62.68 -0.20 (-0.32%)

Closing price 04:00 PM Eastern

Extended Trading

$62.72 +0.04 (+0.06%)

As of 07:34 PM Eastern

Compare

EXPO vs. VSEC, FCN, IHS, CBZ, and HURN

Should you buy Exponent stock or one of its competitors? MarketBeat compares Exponent with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Exponent include VSE (VSEC), FTI Consulting (FCN), IHS (IHS), CBIZ (CBZ), and Huron Consulting Group (HURN). These companies are all part of the "research & consulting services" industry.

How does Exponent compare to VSE?

Exponent (NASDAQ:EXPO) and VSE (NASDAQ:VSEC) are both mid-cap research & consulting services companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, analyst recommendations, valuation, risk, media sentiment and dividends.

92.4% of Exponent shares are held by institutional investors. Comparatively, 91.5% of VSE shares are held by institutional investors. 1.6% of Exponent shares are held by insiders. Comparatively, 1.8% of VSE shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Exponent pays an annual dividend of $1.24 per share and has a dividend yield of 2.0%. VSE pays an annual dividend of $0.40 per share and has a dividend yield of 0.2%. Exponent pays out 57.7% of its earnings in the form of a dividend. VSE pays out 16.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Exponent has raised its dividend for 12 consecutive years. Exponent is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Exponent currently has a consensus target price of $77.50, suggesting a potential upside of 23.64%. VSE has a consensus target price of $239.78, suggesting a potential upside of 23.22%. Given Exponent's higher possible upside, analysts clearly believe Exponent is more favorable than VSE.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
VSE	0 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	2 Strong Buy rating(s)	3.00

Exponent has higher earnings, but lower revenue than VSE. Exponent is trading at a lower price-to-earnings ratio than VSE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exponent	$582.01M	5.22	$106.01M	$2.15	29.15
VSE	$1.11B	4.91	$11.70M	$2.37	82.11

In the previous week, Exponent had 3 more articles in the media than VSE. MarketBeat recorded 7 mentions for Exponent and 4 mentions for VSE. VSE's average media sentiment score of 1.22 beat Exponent's score of 0.37 indicating that VSE is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Exponent	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
VSE	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Exponent has a net margin of 18.07% compared to VSE's net margin of 4.95%. Exponent's return on equity of 27.94% beat VSE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exponent	18.07%	27.94%	14.59%
VSE	4.95%	6.56%	4.68%

Exponent has a beta of 0.72, suggesting that its share price is 28% less volatile than the broader market. Comparatively, VSE has a beta of 1.21, suggesting that its share price is 21% more volatile than the broader market.

Summary

Exponent and VSE tied by winning 10 of the 20 factors compared between the two stocks.

How does Exponent compare to FTI Consulting?

Exponent (NASDAQ:EXPO) and FTI Consulting (NYSE:FCN) are both mid-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, analyst recommendations, valuation, profitability, earnings, dividends and media sentiment.

Exponent has a net margin of 18.07% compared to FTI Consulting's net margin of 6.88%. Exponent's return on equity of 27.94% beat FTI Consulting's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exponent	18.07%	27.94%	14.59%
FTI Consulting	6.88%	15.14%	7.63%

Exponent has a beta of 0.72, indicating that its share price is 28% less volatile than the broader market. Comparatively, FTI Consulting has a beta of -0.04, indicating that its share price is 104% less volatile than the broader market.

Exponent currently has a consensus price target of $77.50, suggesting a potential upside of 23.64%. FTI Consulting has a consensus price target of $174.50, suggesting a potential upside of 8.50%. Given Exponent's stronger consensus rating and higher possible upside, analysts clearly believe Exponent is more favorable than FTI Consulting.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
FTI Consulting	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

FTI Consulting has higher revenue and earnings than Exponent. FTI Consulting is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exponent	$582.01M	5.22	$106.01M	$2.15	29.15
FTI Consulting	$3.79B	1.28	$270.87M	$8.41	19.12

In the previous week, Exponent had 1 more articles in the media than FTI Consulting. MarketBeat recorded 7 mentions for Exponent and 6 mentions for FTI Consulting. Exponent's average media sentiment score of 0.37 beat FTI Consulting's score of 0.30 indicating that Exponent is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Exponent	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
FTI Consulting	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

92.4% of Exponent shares are owned by institutional investors. Comparatively, 99.4% of FTI Consulting shares are owned by institutional investors. 1.6% of Exponent shares are owned by insiders. Comparatively, 1.8% of FTI Consulting shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Exponent beats FTI Consulting on 11 of the 16 factors compared between the two stocks.

How does Exponent compare to IHS?

Exponent (NASDAQ:EXPO) and IHS (NYSE:IHS) are both mid-cap research & consulting services companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

In the previous week, Exponent had 3 more articles in the media than IHS. MarketBeat recorded 7 mentions for Exponent and 4 mentions for IHS. Exponent's average media sentiment score of 0.37 beat IHS's score of 0.14 indicating that Exponent is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Exponent	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
IHS	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Exponent presently has a consensus target price of $77.50, suggesting a potential upside of 23.64%. IHS has a consensus target price of $8.38, suggesting a potential upside of 2.57%. Given Exponent's stronger consensus rating and higher probable upside, equities analysts plainly believe Exponent is more favorable than IHS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
IHS	1 Sell rating(s)	5 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.13

IHS has higher revenue and earnings than Exponent. IHS is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exponent	$582.01M	5.22	$106.01M	$2.15	29.15
IHS	$1.58B	1.73	$143.60M	$0.53	15.41

Exponent has a net margin of 18.07% compared to IHS's net margin of 10.74%. Exponent's return on equity of 27.94% beat IHS's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exponent	18.07%	27.94%	14.59%
IHS	10.74%	-1,351.44%	12.81%

Exponent has a beta of 0.72, indicating that its stock price is 28% less volatile than the broader market. Comparatively, IHS has a beta of 0.73, indicating that its stock price is 27% less volatile than the broader market.

92.4% of Exponent shares are owned by institutional investors. Comparatively, 17.5% of IHS shares are owned by institutional investors. 1.6% of Exponent shares are owned by insiders. Comparatively, 1.1% of IHS shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Exponent beats IHS on 12 of the 15 factors compared between the two stocks.

How does Exponent compare to CBIZ?

Exponent (NASDAQ:EXPO) and CBIZ (NYSE:CBZ) are both mid-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability, earnings and media sentiment.

CBIZ has higher revenue and earnings than Exponent. CBIZ is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exponent	$582.01M	5.22	$106.01M	$2.15	29.15
CBIZ	$2.76B	0.81	$115.44M	$2.49	16.80

Exponent has a net margin of 18.07% compared to CBIZ's net margin of 5.57%. Exponent's return on equity of 27.94% beat CBIZ's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exponent	18.07%	27.94%	14.59%
CBIZ	5.57%	12.62%	5.17%

Exponent currently has a consensus target price of $77.50, suggesting a potential upside of 23.64%. CBIZ has a consensus target price of $39.25, suggesting a potential downside of 6.16%. Given Exponent's higher probable upside, equities research analysts clearly believe Exponent is more favorable than CBIZ.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
CBIZ	1 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.50

92.4% of Exponent shares are owned by institutional investors. Comparatively, 87.4% of CBIZ shares are owned by institutional investors. 1.6% of Exponent shares are owned by company insiders. Comparatively, 4.1% of CBIZ shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Exponent has a beta of 0.72, indicating that its stock price is 28% less volatile than the broader market. Comparatively, CBIZ has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

In the previous week, Exponent had 5 more articles in the media than CBIZ. MarketBeat recorded 7 mentions for Exponent and 2 mentions for CBIZ. CBIZ's average media sentiment score of 0.93 beat Exponent's score of 0.37 indicating that CBIZ is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Exponent	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
CBIZ	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Exponent and CBIZ tied by winning 8 of the 16 factors compared between the two stocks.

How does Exponent compare to Huron Consulting Group?

Exponent (NASDAQ:EXPO) and Huron Consulting Group (NASDAQ:HURN) are both business services companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, media sentiment, dividends, earnings and risk.

Exponent has a beta of 0.72, indicating that its share price is 28% less volatile than the broader market. Comparatively, Huron Consulting Group has a beta of 0.12, indicating that its share price is 88% less volatile than the broader market.

Exponent has higher earnings, but lower revenue than Huron Consulting Group. Huron Consulting Group is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Exponent	$582.01M	5.22	$106.01M	$2.15	29.15
Huron Consulting Group	$1.70B	1.07	$105.04M	$5.86	19.22

In the previous week, Exponent had 4 more articles in the media than Huron Consulting Group. MarketBeat recorded 7 mentions for Exponent and 3 mentions for Huron Consulting Group. Huron Consulting Group's average media sentiment score of 0.68 beat Exponent's score of 0.37 indicating that Huron Consulting Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Exponent	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Huron Consulting Group	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Exponent presently has a consensus price target of $77.50, suggesting a potential upside of 23.64%. Huron Consulting Group has a consensus price target of $184.25, suggesting a potential upside of 63.59%. Given Huron Consulting Group's stronger consensus rating and higher possible upside, analysts clearly believe Huron Consulting Group is more favorable than Exponent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Exponent	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.50
Huron Consulting Group	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80

Exponent has a net margin of 18.07% compared to Huron Consulting Group's net margin of 5.94%. Huron Consulting Group's return on equity of 29.41% beat Exponent's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Exponent	18.07%	27.94%	14.59%
Huron Consulting Group	5.94%	29.41%	9.10%

92.4% of Exponent shares are owned by institutional investors. Comparatively, 93.9% of Huron Consulting Group shares are owned by institutional investors. 1.6% of Exponent shares are owned by insiders. Comparatively, 2.1% of Huron Consulting Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Huron Consulting Group beats Exponent on 9 of the 16 factors compared between the two stocks.

Get Exponent News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EXPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EXPO vs. The Competition

Export

Metric	Exponent	Consulting Industry	Business Sector	NASDAQ Exchange
Market Cap	$3.04B	$4.17B	$6.82B	$12.28B
Dividend Yield	1.97%	2.61%	3.06%	9.36%
P/E Ratio	29.15	20.55	28.43	23.96
Price / Sales	5.22	1.98	341.18	112.12
Price / Cash	27.02	11.90	22.57	47.27
Price / Book	8.02	5.53	5.66	6.14
Net Income	$106.01M	$245.85M	$203.13M	$331.74M
7 Day Performance	-1.43%	0.53%	-2.06%	-1.72%
1 Month Performance	10.18%	8.05%	1.09%	-1.44%
1 Year Performance	-13.56%	-24.28%	8.77%	16.97%

Exponent Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EXPO Exponent	4.389 of 5 stars	$62.68 -0.3%	$77.50 +23.6%	-13.3%	$3.04B	$582.01M	29.15	1,212
VSEC VSE	4.4653 of 5 stars	$205.25 -2.9%	$241.44 +17.6%	+51.9%	$5.93B	$1.11B	86.60	1,600	Positive News Gap Up
FCN FTI Consulting	3.6579 of 5 stars	$161.80 +3.1%	$174.50 +7.9%	-1.0%	$4.73B	$3.79B	19.24	8,118
IHS IHS	1.296 of 5 stars	$8.22 -0.8%	$8.38 +1.9%	+38.2%	$2.78B	$1.58B	15.50	2,762
CBZ CBIZ	3.2913 of 5 stars	$40.49 +7.1%	$39.25 -3.1%	-43.2%	$2.03B	$2.76B	16.26	9,500

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:EXPO) was last updated on 7/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Exponent (EXPO) Competitors